Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction

• Status: Completed
• Trial end date: 2020-06-26
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to investigate the possible effects of supplementation with 1.8 g/day of n-3 polyunsaturated fatty acids on cardiovascular morbidity and mortality during a follow-up period of 2 years in an elderly population after having experienced an acute myocardial infarction.

The hypothesis is that this supplementation on top of modern therapy will reduce the combined cardiovascular end-point of death, non-fatal myocardial infarction, stroke, revascularizations or hospitalization for new or worsened heart failure with at least 30%.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Oslo University Hospital
• Collaborators: Asker & Baerum Hospital; Helse Stavanger HF; University Hospital, Akershus

Criteria

Inclusion Criteria:

• Patients with acute myocardial infarction discharged from hospital alive

Exclusion Criteria:

• Being part of another randomized trial

• Documented intolerance for omega-3 fatty acids

• Additional disease state that is thought to be incompatible with compliance to the study drugs

• Additional disease state thought to reduce survival for the follow-up time of 2 years